Ranitidine Recalls Begin In Europe As Regulators Take Action

OTC products are among the first to be recalled in Europe following the discovery of a human carcinogen in ranitidine-based drugs.With investigations underway worldwide, regulators across Europe are split into two camps: immediate action or wait and see.

Nitrosodimethylamine
• Source: Shutterstock

Germany, Switzerland and Austria are the first European countries to initiate recalls of ranitidine-based drugs after tests showed that certain products contained N-nitrosodimethylamine, a probable human carcinogen.

With a Europe-wide review of ranitidine underway at the European Medicines Agency, national regulators in the DACH region are overseeing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography